1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Indirect comparison of dabigatran, rivaroxaban and apixaban for venous thromboembolic disease
    Meeting Abstract

    Mantha, S.; Ansell, J.
    Blood (2013)

    Fulltext@MSK | Save
  • Predicting INR time in the therapeutic range: A Bayesian approach
    Meeting Abstract

    Mantha, S.; Rose, A.; Moll, S.
    Blood (2013)

    Fulltext@MSK | Save
  • A proposed prognostic model for overall survival in the oldest old (>80 years old) follicular lymphoma patients
    Meeting Abstract

    Nabhan, C.; Byrtek, M.; Dawson, K. L.; Zhou, X.; Link, B. K.; Friedberg, J. W.; Zelenetz, A. D.; Cerhan, J. R.; Flowers, C. R.
    Blood (2013)

    Fulltext@MSK | Save
  • Angiopoietin-like proteins stimulate HSC development through direct interaction with notch
    Meeting Abstract

    Lin, M. I.; Price, E.; Boatman, S.; Trompouki, E.; Satishchandran, S.; Carspecken, C. W.; Uong, A.; DiBiase, A.; Aster, J. C.; White, R. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Multiple copies of MLL is the most commonly detected cytogenetic abnormality in newly diagnosed multiple myeloma and may modify disease risk
    Meeting Abstract

    Landry, C.; Londono, D.; Devlin, S. M.; Lesokhin, A.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; Jhanwar, S. C.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Prognostic impact of MLL5 transcript levels on outcome of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: An International Consortium on Acute Promyelocytic Leukemia study
    Meeting Abstract

    Lucena-Araujo, A. R.; Kim, H. T.; Jacomo, R.; Melo, R. A.; Bittencourt, R.; Pasquini, R.; Pagnano, K. B.; Fagundes, E.; Chauffaille, M. d. L. L. F; Lima, A. S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations in hematologic malignancies by a clinical next generation sequencing-based assay
    Meeting Abstract

    Lipson, D.; Nahas, M. K.; Otto, G. A.; Yelensky, R.; Abdel-Wahab, O.; Wang, K.; He, J.; Intlekofer, A. M.; Rampal, R. K.; Brennan, T. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Myeloid leukemia cells with MLL partial tandem duplication are sensitive to pharmacological inhibition of the H3K79 methyltransferase DOT1L
    Meeting Abstract

    Kühn, M. W. M.; Hadler, M.; Daigle, S. R.; Chen, C. W.; Sinha, A. U.; Krivtsov, A. V.; Olhava, E. J.; Caligiuri, M. A.; Bradner, J. E.; Pollock, R. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Excellent outcomes for limited-stage diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis from Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Kumar, A.; Maragulia, J. C.; Lunning, M. A.; Moskowitz, C. H.; Zelenetz, A. D.
    Blood (2013)

    Fulltext@MSK | Save